THE SUBJECT-BY-FORMULATION INTERACTION AS A CRITERION OF INTERCHANGEABILITY OF DRUGS

被引：46

作者：

EKBOHM, G ^{[1
]}

MELANDER, H ^{[1
]}

机构：

[1] NATL BOARD HLTH & WELF,DEPT DRUGS,S-75125 UPPSALA,SWEDEN

来源：

关键词：

D O I：

10.2307/2531776

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：1249 / 1254

页数：6

共 16 条

[1]

ALBERT KS, 1980, DRUG ABSORPTION DISP, P87

[2]

ARMITAGE P, 1982, STATISTICIAN, V31, P119

[3]

BRONLEE KA, 1965, STATISTICAL THEORY M

[4] CROSSOVER EXPERIMENT FOR CLINICAL-TRIALS [J].

BROWN, BW .

[5]

Cox DR., 1958, PLANNING EXPT

[6] 3-PERIOD CROSSOVER DESIGNS FOR 2 TREATMENTS [J].

EBBUTT, AF .

[7]

GRAHNEN A, 1984, EUR J CLIN PHARMACOL, V27, P595, DOI 10.1007/BF00556898

[8] 2-PERIOD CHANGE-OVER DESIGN AND ITS USE IN CLINICAL TRIALS [J].

GRIZZLE, JE .

HAYNES, JD .

[10] 2-PERIOD CROSSOVER CLINICAL-TRIAL [J].

HILLS, M ;

ARMITAGE, P .